Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Wellcome Open Research|October 23, 2018
B cell, CD8 + T cell and gamma delta T cell infiltration alters alveolar immune cell homeostasis in HIV-infected Malawian adultsAndrew Mwale, Annemarie Hummel, Leonard Mvaya, et al.
Scientific Reports|November 17, 2020
TZM-gfp cells: a tractable fluorescent tool for analysis of rare and early HIV-1 infectionDavid W Gludish, Saikat Boliar, Shannon Caldwell, et al.
Frontiers in Immunology|September 10, 2019
Airway CD8+CD161++TCRvα7.2+ T Cell Depletion During Untreated HIV Infection Targets CD103 Expressing CellsLeonard Mvaya, Andrew Mwale, Annemarie Hummel, et al.
Microbes and Infection|July 24, 2007
Alveolar macrophages from HIV-infected patients with pulmonary tuberculosis retain the capacity to respond to stimulation by lipopolysaccharideHenry C Mwandumba, S Bertel Squire, Sarah A White, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2022
How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Thomas S Harrison, David S Lawrence, Henry C Mwandumba, et al.
Open Forum Infectious Diseases|August 1, 2020
Longitudinal Pharmacokinetic-Pharmacodynamic Biomarkers Correlate With Treatment Outcome in Drug-Sensitive Pulmonary Tuberculosis: A Population Pharmacokinetic-Pharmacodynamic AnalysisFrank Kloprogge, Henry C Mwandumba, Gertrude Banda, et al.
BMC Cardiovascular Disorders|December 21, 2022
High prevalence of dyslipidaemia among persons with diabetes mellitus and hypertension at a tertiary hospital in Blantyre, MalawiKondwani G H Katundu, Victoria Mukhula, Tamara Phiri, et al.
Tuberculosis (Edinburgh, Scotland)|October 5, 2007
Association between sputum smear status and local immune responses at the site of disease in HIV-infected patients with pulmonary tuberculosisHenry C Mwandumba, S Bertel Squire, Sarah A White, et al.
Vaccine|May 12, 2026
Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01E-4 tuberculosis vaccineAlemnew F Dagnew, Robert Noble, Amy Cinar, et al.
The Lancet. Infectious Diseases|April 19, 2021
Cryptococcal meningoencephalitis: time for actionKatharine Elizabeth Stott, Angela Loyse, Joe N Jarvis, et al.
Pageof 8